2024 Q2 Form 10-Q Financial Statement

#000095017024047691 Filed on April 24, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.066B $1.049B
YoY Change -8.85% 1.18%
Cost Of Revenue $663.9M $634.4M
YoY Change -5.01% 0.78%
Gross Profit $402.5M $414.7M
YoY Change -14.56% 1.79%
Gross Profit Margin 37.74% 39.53%
Selling, General & Admin $211.8M $208.6M
YoY Change -7.31% 2.91%
% of Gross Profit 52.62% 50.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $46.10M $46.60M
YoY Change 0.44% 356.86%
% of Gross Profit 11.45% 11.24%
Operating Expenses $211.8M $208.6M
YoY Change -7.31% 2.91%
Operating Profit $190.7M $206.1M
YoY Change -21.39% 0.68%
Interest Expense -$27.40M -$23.00M
YoY Change 20.18% 5.5%
% of Operating Profit -14.37% -11.16%
Other Income/Expense, Net -$25.50M $900.0K
YoY Change 650.0% -103.8%
Pretax Income $165.2M $170.0M
YoY Change -23.66% -6.08%
Income Tax $24.20M $27.30M
% Of Pretax Income 14.65% 16.06%
Net Earnings $141.0M $142.7M
YoY Change -19.98% -5.99%
Net Earnings / Revenue 13.22% 13.6%
Basic Earnings Per Share $0.42 $0.41
Diluted Earnings Per Share $0.41 $0.41
COMMON SHARES
Basic Shares Outstanding 338.3M 342.2M
Diluted Shares Outstanding 339.6M 345.7M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.033B $1.107B
YoY Change -34.86% -9.94%
Cash & Equivalents $1.033B $1.107B
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.033B $1.107B
YoY Change -34.86% -9.94%
LONG-TERM ASSETS
Property, Plant & Equipment $82.60M $88.60M
YoY Change -14.23% -14.06%
Goodwill $2.056B $2.050B
YoY Change 1.07% 0.73%
Intangibles $347.0M $369.0M
YoY Change -19.36% -16.17%
Long-Term Investments
YoY Change
Other Assets $17.70M $21.90M
YoY Change -93.53% -92.36%
Total Long-Term Assets $6.938B $6.947B
YoY Change 0.53% -0.83%
TOTAL ASSETS
Total Short-Term Assets $1.033B $1.107B
Total Long-Term Assets $6.938B $6.947B
Total Assets $7.971B $8.053B
YoY Change -6.08% -2.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $376.5M $392.7M
YoY Change -9.97% -4.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $494.8M $399.9M
YoY Change -26.65% 1499.6%
Long-Term Debt Due $500.0M $500.0M
YoY Change 66.67%
Total Short-Term Liabilities $1.825B $1.962B
YoY Change 5.62% 32.84%
LONG-TERM LIABILITIES
Long-Term Debt $1.641B $1.640B
YoY Change -23.26% -23.26%
Other Long-Term Liabilities $3.920B $3.904B
YoY Change 2.08% 0.01%
Total Long-Term Liabilities $5.561B $5.544B
YoY Change -6.98% -8.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.825B $1.962B
Total Long-Term Liabilities $5.561B $5.544B
Total Liabilities $7.531B $7.655B
YoY Change -4.2% -0.33%
SHAREHOLDERS EQUITY
Retained Earnings -$451.3M -$485.0M
YoY Change 114.5% 63.41%
Common Stock $1.054B $1.044B
YoY Change 3.63% 3.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $440.8M $397.9M
YoY Change
Total Liabilities & Shareholders Equity $7.971B $8.053B
YoY Change -6.08% -2.19%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $141.0M $142.7M
YoY Change -19.98% -5.99%
Depreciation, Depletion And Amortization $46.10M $46.60M
YoY Change 0.44% 356.86%
Cash From Operating Activities -$33.80M $94.00M
YoY Change -126.68% -31.54%
INVESTING ACTIVITIES
Capital Expenditures $26.60M $32.70M
YoY Change -13.64% 380.88%
Acquisitions
YoY Change
Other Investing Activities -$35.50M $26.40M
YoY Change -1790.48% -2500.0%
Cash From Investing Activities -$62.10M -$6.300M
YoY Change 116.38% -82.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.50M -333.1M
YoY Change -108.61% 139.64%
NET CHANGE
Cash From Operating Activities -33.80M 94.00M
Cash From Investing Activities -62.10M -6.300M
Cash From Financing Activities 40.50M -333.1M
Net Change In Cash -55.40M -245.4M
YoY Change -85.13% 544.09%
FREE CASH FLOW
Cash From Operating Activities -$33.80M $94.00M
Capital Expenditures $26.60M $32.70M
Free Cash Flow -$60.40M $61.30M
YoY Change -162.98% -53.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001365135
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2024Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2023Q1 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2023#ServiceMember
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2017 2018
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-32903
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
THE WESTERN UNION COMPANY
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4531180
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
7001 EAST BELLEVIEW AVENUE
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80237
CY2024Q1 dei City Area Code
CityAreaCode
866
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
405-5012
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value
CY2024Q1 dei Trading Symbol
TradingSymbol
WU
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
338335142
CY2024Q1 us-gaap Revenues
Revenues
1049100000
CY2023Q1 us-gaap Revenues
Revenues
1036900000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
641300000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
629500000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
215700000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
202700000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
857000000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
832200000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
192100000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
204700000
CY2024Q1 us-gaap Investment Income Net
InvestmentIncomeNet
3100000
CY2023Q1 us-gaap Investment Income Net
InvestmentIncomeNet
3200000
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
26100000
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25000000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
900000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1900000
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22100000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-23700000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
170000000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
181000000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
27300000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29200000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
142700000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
151800000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.41
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.4
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344400000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
374400000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
345700000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
375500000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
142700000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
151800000
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4600000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
20000000
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
10800000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-10300000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6200000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9700000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
148900000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
161500000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1106500000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1268600000
CY2024Q1 us-gaap Settlement Assets Current
SettlementAssetsCurrent
3635600000
CY2023Q4 us-gaap Settlement Assets Current
SettlementAssetsCurrent
3687000000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
446100000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
438800000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88600000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91400000
CY2024Q1 us-gaap Goodwill
Goodwill
2049500000
CY2023Q4 us-gaap Goodwill
Goodwill
2034600000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
685600000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
685900000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
369000000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
380200000
CY2024Q1 us-gaap Other Assets
OtherAssets
804000000
CY2023Q4 us-gaap Other Assets
OtherAssets
737000000
CY2024Q1 us-gaap Assets
Assets
8053200000
CY2023Q4 us-gaap Assets
Assets
8198800000
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
392700000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
453000000
CY2024Q1 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
3635600000
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
3687000000
CY2024Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
668900000
CY2023Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
659500000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
149400000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
147600000
CY2024Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
2540300000
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
2504600000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
268400000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
268100000
CY2024Q1 us-gaap Liabilities
Liabilities
7655300000
CY2023Q4 us-gaap Liabilities
Liabilities
7719800000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
339600000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
339600000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
350500000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
350500000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
3400000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3500000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1040600000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1031900000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-485000000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-389100000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-161100000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-167300000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
397900000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
479000000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8053200000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8198800000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
142700000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
151800000
CY2024Q1 us-gaap Depreciation
Depreciation
9200000
CY2023Q1 us-gaap Depreciation
Depreciation
10200000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
37400000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36400000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-20000000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-19300000
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
46600000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
28100000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-64400000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-62200000
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
8800000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
17200000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-13100000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-7300000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
94000000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
137300000
CY2024Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2400000
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31000000
CY2024Q1 us-gaap Payments For Software
PaymentsForSoftware
21700000
CY2023Q1 us-gaap Payments For Software
PaymentsForSoftware
19600000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6800000
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
24500000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1100000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6300000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36400000
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
80500000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
88100000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150600000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5100000
CY2024Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
35000000
CY2023Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-155000000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
300000
CY2024Q1 wu Net Change In Settlement Obligations
NetChangeInSettlementObligations
136900000
CY2023Q1 wu Net Change In Settlement Obligations
NetChangeInSettlementObligations
-109100000
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-100000
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-200000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-333100000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-139000000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-245400000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38100000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1786200000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2040700000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1540800000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2002600000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1106500000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1228600000
CY2024Q1 wu Settlement Assets Cash And Cash Equivalents
SettlementAssetsCashAndCashEquivalents
412400000
CY2023Q1 wu Settlement Assets Cash And Cash Equivalents
SettlementAssetsCashAndCashEquivalents
737100000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
21900000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
36900000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1540800000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2002600000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
21400000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
16900000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17100000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13300000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
479000000
CY2023Q1 us-gaap Revenues
Revenues
1036900000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
142700000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8700000
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.235
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
81900000
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
156800000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6200000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
397900000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
477800000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
151800000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000000
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.235
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
88600000
CY2023Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
6200000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
300000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9700000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
552800000
CY2024Q1 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
200
CY2023Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
440000000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates.</span></p>
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
995700000
CY2024Q1 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
53400000
CY2024Q1 us-gaap Revenues
Revenues
1049100000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
979000000
CY2023Q1 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
57900000
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
150000000
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11400000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9200000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
344400000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
374400000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1300000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1100000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
345700000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
375500000
CY2017 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
6
CY2017 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
22400000
CY2024Q1 wu Settlement Assets Cash And Cash Equivalents
SettlementAssetsCashAndCashEquivalents
412400000
CY2023Q4 wu Settlement Assets Cash And Cash Equivalents
SettlementAssetsCashAndCashEquivalents
496000000
CY2024Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1832200000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1748300000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11900000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
15400000
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
1820300000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
1732900000
CY2024Q1 wu Settlement Assets Investment Securities
SettlementAssetsInvestmentSecurities
1403000000
CY2023Q4 wu Settlement Assets Investment Securities
SettlementAssetsInvestmentSecurities
1458200000
CY2024Q1 wu Settlement Assets Allowance For Credit Losses
SettlementAssetsAllowanceForCreditLosses
100000
CY2023Q4 wu Settlement Assets Allowance For Credit Losses
SettlementAssetsAllowanceForCreditLosses
100000
CY2024Q1 wu Settlement Assets Investment Securities Net
SettlementAssetsInvestmentSecuritiesNet
1402900000
CY2023Q4 wu Settlement Assets Investment Securities Net
SettlementAssetsInvestmentSecuritiesNet
1458100000
CY2024Q1 wu Settlement Assets Including Discontinued Operations Current
SettlementAssetsIncludingDiscontinuedOperationsCurrent
3635600000
CY2023Q4 wu Settlement Assets Including Discontinued Operations Current
SettlementAssetsIncludingDiscontinuedOperationsCurrent
3687000000
CY2024Q1 wu Settlement Obligations Money Transfer Money Order And Payment Service Payables
SettlementObligationsMoneyTransferMoneyOrderAndPaymentServicePayables
2940700000
CY2023Q4 wu Settlement Obligations Money Transfer Money Order And Payment Service Payables
SettlementObligationsMoneyTransferMoneyOrderAndPaymentServicePayables
2764500000
CY2024Q1 wu Settlement Obligations Payables To Agents
SettlementObligationsPayablesToAgents
694900000
CY2023Q4 wu Settlement Obligations Payables To Agents
SettlementObligationsPayablesToAgents
922500000
CY2024Q1 wu Settlement Liabilities Including Discontinued Operations Current
SettlementLiabilitiesIncludingDiscontinuedOperationsCurrent
3635600000
CY2023Q4 wu Settlement Liabilities Including Discontinued Operations Current
SettlementLiabilitiesIncludingDiscontinuedOperationsCurrent
3687000000
CY2024Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
14800000
CY2023Q1 us-gaap Provision For Other Losses
ProvisionForOtherLosses
9100000
CY2024Q1 wu Variable Rate Demand Notes Maximum Maturity Year
VariableRateDemandNotesMaximumMaturityYear
2052
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
95800000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
563400000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Rolling Year Six Through Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearSixThroughTenFairValue
454100000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Rolling After Year Ten Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingAfterYearTenFairValue
289700000
CY2024Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
1403000000
CY2024Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
4800000
CY2023Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
8100000
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.235
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.235
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
80100000
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
88000000
CY2024Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2024-03-29
CY2023Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-03-31
CY2024Q1 wu Stock Repurchased And Retired During Period Excluding Wtc Shares
StockRepurchasedAndRetiredDuringPeriodExcludingWTCShares
11800000
CY2024Q1 wu Stock Repurchased And Retired During Period Excluding Wt Cand Commissions Value
StockRepurchasedAndRetiredDuringPeriodExcludingWTCandCommissionsValue
150000000
CY2024Q1 wu Stock Repurchased And Retired During Period Excluding Wtc And Commissions Average Cost Per Share
StockRepurchasedAndRetiredDuringPeriodExcludingWTCAndCommissionsAverageCostPerShare
12.66
CY2024Q1 us-gaap Derivative Assets
DerivativeAssets
15700000
CY2023Q4 us-gaap Derivative Assets
DerivativeAssets
10800000
CY2024Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
6700000
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
17400000
CY2024Q1 wu Gain Loss Excluded From Effectiveness Testing Recognized In Other Comprehensive Income Based On Amortization Approach
GainLossExcludedFromEffectivenessTestingRecognizedInOtherComprehensiveIncomeBasedOnAmortizationApproach
-900000
CY2023Q1 wu Gain Loss Excluded From Effectiveness Testing Recognized In Other Comprehensive Income Based On Amortization Approach
GainLossExcludedFromEffectivenessTestingRecognizedInOtherComprehensiveIncomeBasedOnAmortizationApproach
1800000
CY2024Q1 us-gaap Revenues
Revenues
1049100000
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
26100000
CY2023Q1 us-gaap Revenues
Revenues
1036900000
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
25000000
CY2024Q1 wu Foreign Exchange Gain Loss On Settlement Assets And Obligations Other Assets And Other Liabilities And Cash Balances
ForeignExchangeGainLossOnSettlementAssetsAndObligationsOtherAssetsAndOtherLiabilitiesAndCashBalances
-17500000
CY2023Q1 wu Foreign Exchange Gain Loss On Settlement Assets And Obligations Other Assets And Other Liabilities And Cash Balances
ForeignExchangeGainLossOnSettlementAssetsAndObligationsOtherAssetsAndOtherLiabilitiesAndCashBalances
200000
CY2024Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
200000
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2549900000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2514900000
CY2024Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
9600000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
10300000
CY2024Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
2540300000
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
2504600000
CY2024Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.04
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
500000000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
600000000
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
1050000000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
2150000000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.16
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.161
CY2024Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
310000000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
309700000
CY2024Q1 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
250000000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8700000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8000000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4400000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.8
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
4100000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.69
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11000000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.08
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4700000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
19.07
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
9200000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.35
CY2024Q1 us-gaap Revenues
Revenues
1049100000
CY2023Q1 us-gaap Revenues
Revenues
1036900000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
192100000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
204700000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-047691-index-headers.html Edgar Link pending
0000950170-24-047691-index.html Edgar Link pending
0000950170-24-047691.txt Edgar Link pending
0000950170-24-047691-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img156424880_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wu-20240331.htm Edgar Link pending
wu-20240331.xsd Edgar Link pending
wu-ex15.htm Edgar Link pending
wu-ex31_1.htm Edgar Link pending
wu-ex31_2.htm Edgar Link pending
wu-ex32.htm Edgar Link pending
wu-20240331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable